Pender v Punter Southall Group Limited [2026] JCA 039

April 29, 2026

This appeal arose from an unfair prejudice claim brought by Daniel Pender, the minority shareholder in GGH (Jersey) Limited, whose principal asset was Guardian Financial Services Limited, a distributor of life and protection products underwritten by Scottish Friendly Association. Following a lengthy trial, the Royal Court concluded in 2023 that PSG, the majority shareholder, had conducted the company’s affairs unfairly and ordered a compulsory buyout at fair value.

The Court approved a venture capital valuation methodology using (i) a forecast EBITDA at an exit year, (ii) a multiple derived from the 2014 PruProtect transaction, and (iii) discounting to present value. In subsequent valuation hearings, it set key inputs including the choice of forecasting model, the uplift to projected sales, use of “best estimate” (non IFRS adjusted) in force book values, a 15x exit multiple, and a 21% cost of equity. After further expert evidence, the Royal Court in 2025 fixed the company’s enterprise value at £237 million and Pender’s 18% shareholding at £42.7 million. A contentious element was the treatment of the SFA Advance Commission facility: the Court applied an £11 million downward adjustment.

On appeal, PSG advanced wide ranging criticisms, including alleged prejudgment, errors in expert preference, failure to consider subsequent under performance, incorrect modelling choices, improper rejection of the Evercore indicative valuation, and inadequate treatment of the SFA facility. PSG also applied to admit fresh evidence. Mr Pender cross appealed, arguing that no adjustment should have been made for the SFA facility at all.

The Court of Appeal rejected complaints of prejudgment and found the interim payment order unproblematic. It held that the Royal Court had properly exercised its evaluative judgment when choosing between competing expert analyses, determining forecasting assumptions, selecting the exit multiple, deciding the discount rate, and excluding the Evercore valuation. It also affirmed that courts valuing shares at a set valuation date are generally not required—and in many cases not permitted—to adjust inputs retrospectively based on post valuation performance; nor must they adopt hindsight or “sense checks” based on later events. The Royal Court’s refusal to revisit findings in light of data produced in 2024 was therefore within orthodox principles of valuation law.
The only error identified concerned the SFA facility. The Court of Appeal found that the Royal Court had misunderstood how each expert’s adjustment operated, treating two superficially similar figures as commensurate when they were premised on different baselines. This was a material error requiring remittal. The Court dismissed PSG’s remaining grounds and dismissed Mr Pender’s cross appeal.

Comment

This judgment is significant for valuation cases arising from unfair prejudice petitions, particularly those involving early stage or high growth businesses with complex financing structures. The Court of Appeal reaffirms the high degree of deference owed to a trial court's evaluative judgments, especially where the Royal Court has immersed itself in extensive expert and factual evidence over multiple hearings. It emphasises that disagreements over methodology, inputs, or expert preference will rarely justify appellate intervention unless the resulting valuation is outside the permissible range or rests on a demonstrable misunderstanding.

Importantly, the Court provides a clear restatement of the non hindsight principle in share valuation: once a valuation date is fixed, later developments—whether favourable or unfavourable—do not ordinarily justify reopening findings or altering forecasts that were reasonable at the time. This prevents valuations from becoming perpetually adjustable and preserves finality in commercial disputes. Similarly, while “sense checks” are sometimes appropriate, courts cannot displace a structured and expert driven valuation merely because subsequent events or instinctive impressions cast doubt on the headline figure.

The sole error identified—the misapplication of the SFA facility adjustment—serves as a reminder that even in broad evaluative exercises, courts must apply expert evidence with care. When complex financial instruments are involved, apparently similar numerical outcomes may conceal materially different methodologies, requiring careful scrutiny. The remittal also underscores that appellate courts will intervene where a valuation rests on an internally inconsistent rationale.

Overall, the decision consolidates a trend in Jersey case law: valuation in unfair prejudice cases is an evaluative, not mechanical, exercise; expert evidence must be weighed holistically; and appellate correction is exceptional, reserved for errors that undermine the coherence of the valuation rather than disagreements over its magnitude.
consideration has been overlooked.

This appeal arose from an unfair prejudice claim brought by Daniel Pender, the minority shareholder in GGH (Jersey) Limited, whose principal asset was Guardian Financial Services Limited, a distributor of life and protection products underwritten by Scottish Friendly Association. Following a lengthy trial, the Royal Court concluded in 2023 that PSG, the majority shareholder, had conducted the company’s affairs unfairly and ordered a compulsory buyout at fair value.

The Court approved a venture capital valuation methodology using (i) a forecast EBITDA at an exit year, (ii) a multiple derived from the 2014 PruProtect transaction, and (iii) discounting to present value. In subsequent valuation hearings, it set key inputs including the choice of forecasting model, the uplift to projected sales, use of “best estimate” (non IFRS adjusted) in force book values, a 15x exit multiple, and a 21% cost of equity. After further expert evidence, the Royal Court in 2025 fixed the company’s enterprise value at £237 million and Pender’s 18% shareholding at £42.7 million. A contentious element was the treatment of the SFA Advance Commission facility: the Court applied an £11 million downward adjustment.

On appeal, PSG advanced wide ranging criticisms, including alleged prejudgment, errors in expert preference, failure to consider subsequent under performance, incorrect modelling choices, improper rejection of the Evercore indicative valuation, and inadequate treatment of the SFA facility. PSG also applied to admit fresh evidence. Mr Pender cross appealed, arguing that no adjustment should have been made for the SFA facility at all.

The Court of Appeal rejected complaints of prejudgment and found the interim payment order unproblematic. It held that the Royal Court had properly exercised its evaluative judgment when choosing between competing expert analyses, determining forecasting assumptions, selecting the exit multiple, deciding the discount rate, and excluding the Evercore valuation. It also affirmed that courts valuing shares at a set valuation date are generally not required—and in many cases not permitted—to adjust inputs retrospectively based on post valuation performance; nor must they adopt hindsight or “sense checks” based on later events. The Royal Court’s refusal to revisit findings in light of data produced in 2024 was therefore within orthodox principles of valuation law.
The only error identified concerned the SFA facility. The Court of Appeal found that the Royal Court had misunderstood how each expert’s adjustment operated, treating two superficially similar figures as commensurate when they were premised on different baselines. This was a material error requiring remittal. The Court dismissed PSG’s remaining grounds and dismissed Mr Pender’s cross appeal.

Comment

This judgment is significant for valuation cases arising from unfair prejudice petitions, particularly those involving early stage or high growth businesses with complex financing structures. The Court of Appeal reaffirms the high degree of deference owed to a trial court's evaluative judgments, especially where the Royal Court has immersed itself in extensive expert and factual evidence over multiple hearings. It emphasises that disagreements over methodology, inputs, or expert preference will rarely justify appellate intervention unless the resulting valuation is outside the permissible range or rests on a demonstrable misunderstanding.

Importantly, the Court provides a clear restatement of the non hindsight principle in share valuation: once a valuation date is fixed, later developments—whether favourable or unfavourable—do not ordinarily justify reopening findings or altering forecasts that were reasonable at the time. This prevents valuations from becoming perpetually adjustable and preserves finality in commercial disputes. Similarly, while “sense checks” are sometimes appropriate, courts cannot displace a structured and expert driven valuation merely because subsequent events or instinctive impressions cast doubt on the headline figure.

The sole error identified—the misapplication of the SFA facility adjustment—serves as a reminder that even in broad evaluative exercises, courts must apply expert evidence with care. When complex financial instruments are involved, apparently similar numerical outcomes may conceal materially different methodologies, requiring careful scrutiny. The remittal also underscores that appellate courts will intervene where a valuation rests on an internally inconsistent rationale.

Overall, the decision consolidates a trend in Jersey case law: valuation in unfair prejudice cases is an evaluative, not mechanical, exercise; expert evidence must be weighed holistically; and appellate correction is exceptional, reserved for errors that undermine the coherence of the valuation rather than disagreements over its magnitude.
consideration has been overlooked.

This appeal arose from an unfair prejudice claim brought by Daniel Pender, the minority shareholder in GGH (Jersey) Limited, whose principal asset was Guardian Financial Services Limited, a distributor of life and protection products underwritten by Scottish Friendly Association. Following a lengthy trial, the Royal Court concluded in 2023 that PSG, the majority shareholder, had conducted the company’s affairs unfairly and ordered a compulsory buyout at fair value.

The Court approved a venture capital valuation methodology using (i) a forecast EBITDA at an exit year, (ii) a multiple derived from the 2014 PruProtect transaction, and (iii) discounting to present value. In subsequent valuation hearings, it set key inputs including the choice of forecasting model, the uplift to projected sales, use of “best estimate” (non IFRS adjusted) in force book values, a 15x exit multiple, and a 21% cost of equity. After further expert evidence, the Royal Court in 2025 fixed the company’s enterprise value at £237 million and Pender’s 18% shareholding at £42.7 million. A contentious element was the treatment of the SFA Advance Commission facility: the Court applied an £11 million downward adjustment.

On appeal, PSG advanced wide ranging criticisms, including alleged prejudgment, errors in expert preference, failure to consider subsequent under performance, incorrect modelling choices, improper rejection of the Evercore indicative valuation, and inadequate treatment of the SFA facility. PSG also applied to admit fresh evidence. Mr Pender cross appealed, arguing that no adjustment should have been made for the SFA facility at all.

The Court of Appeal rejected complaints of prejudgment and found the interim payment order unproblematic. It held that the Royal Court had properly exercised its evaluative judgment when choosing between competing expert analyses, determining forecasting assumptions, selecting the exit multiple, deciding the discount rate, and excluding the Evercore valuation. It also affirmed that courts valuing shares at a set valuation date are generally not required—and in many cases not permitted—to adjust inputs retrospectively based on post valuation performance; nor must they adopt hindsight or “sense checks” based on later events. The Royal Court’s refusal to revisit findings in light of data produced in 2024 was therefore within orthodox principles of valuation law.
The only error identified concerned the SFA facility. The Court of Appeal found that the Royal Court had misunderstood how each expert’s adjustment operated, treating two superficially similar figures as commensurate when they were premised on different baselines. This was a material error requiring remittal. The Court dismissed PSG’s remaining grounds and dismissed Mr Pender’s cross appeal.

Comment

This judgment is significant for valuation cases arising from unfair prejudice petitions, particularly those involving early stage or high growth businesses with complex financing structures. The Court of Appeal reaffirms the high degree of deference owed to a trial court's evaluative judgments, especially where the Royal Court has immersed itself in extensive expert and factual evidence over multiple hearings. It emphasises that disagreements over methodology, inputs, or expert preference will rarely justify appellate intervention unless the resulting valuation is outside the permissible range or rests on a demonstrable misunderstanding.

Importantly, the Court provides a clear restatement of the non hindsight principle in share valuation: once a valuation date is fixed, later developments—whether favourable or unfavourable—do not ordinarily justify reopening findings or altering forecasts that were reasonable at the time. This prevents valuations from becoming perpetually adjustable and preserves finality in commercial disputes. Similarly, while “sense checks” are sometimes appropriate, courts cannot displace a structured and expert driven valuation merely because subsequent events or instinctive impressions cast doubt on the headline figure.

The sole error identified—the misapplication of the SFA facility adjustment—serves as a reminder that even in broad evaluative exercises, courts must apply expert evidence with care. When complex financial instruments are involved, apparently similar numerical outcomes may conceal materially different methodologies, requiring careful scrutiny. The remittal also underscores that appellate courts will intervene where a valuation rests on an internally inconsistent rationale.

Overall, the decision consolidates a trend in Jersey case law: valuation in unfair prejudice cases is an evaluative, not mechanical, exercise; expert evidence must be weighed holistically; and appellate correction is exceptional, reserved for errors that undermine the coherence of the valuation rather than disagreements over its magnitude.
consideration has been overlooked.

This appeal arose from an unfair prejudice claim brought by Daniel Pender, the minority shareholder in GGH (Jersey) Limited, whose principal asset was Guardian Financial Services Limited, a distributor of life and protection products underwritten by Scottish Friendly Association. Following a lengthy trial, the Royal Court concluded in 2023 that PSG, the majority shareholder, had conducted the company’s affairs unfairly and ordered a compulsory buyout at fair value.

The Court approved a venture capital valuation methodology using (i) a forecast EBITDA at an exit year, (ii) a multiple derived from the 2014 PruProtect transaction, and (iii) discounting to present value. In subsequent valuation hearings, it set key inputs including the choice of forecasting model, the uplift to projected sales, use of “best estimate” (non IFRS adjusted) in force book values, a 15x exit multiple, and a 21% cost of equity. After further expert evidence, the Royal Court in 2025 fixed the company’s enterprise value at £237 million and Pender’s 18% shareholding at £42.7 million. A contentious element was the treatment of the SFA Advance Commission facility: the Court applied an £11 million downward adjustment.

On appeal, PSG advanced wide ranging criticisms, including alleged prejudgment, errors in expert preference, failure to consider subsequent under performance, incorrect modelling choices, improper rejection of the Evercore indicative valuation, and inadequate treatment of the SFA facility. PSG also applied to admit fresh evidence. Mr Pender cross appealed, arguing that no adjustment should have been made for the SFA facility at all.

The Court of Appeal rejected complaints of prejudgment and found the interim payment order unproblematic. It held that the Royal Court had properly exercised its evaluative judgment when choosing between competing expert analyses, determining forecasting assumptions, selecting the exit multiple, deciding the discount rate, and excluding the Evercore valuation. It also affirmed that courts valuing shares at a set valuation date are generally not required—and in many cases not permitted—to adjust inputs retrospectively based on post valuation performance; nor must they adopt hindsight or “sense checks” based on later events. The Royal Court’s refusal to revisit findings in light of data produced in 2024 was therefore within orthodox principles of valuation law.
The only error identified concerned the SFA facility. The Court of Appeal found that the Royal Court had misunderstood how each expert’s adjustment operated, treating two superficially similar figures as commensurate when they were premised on different baselines. This was a material error requiring remittal. The Court dismissed PSG’s remaining grounds and dismissed Mr Pender’s cross appeal.

Comment

This judgment is significant for valuation cases arising from unfair prejudice petitions, particularly those involving early stage or high growth businesses with complex financing structures. The Court of Appeal reaffirms the high degree of deference owed to a trial court's evaluative judgments, especially where the Royal Court has immersed itself in extensive expert and factual evidence over multiple hearings. It emphasises that disagreements over methodology, inputs, or expert preference will rarely justify appellate intervention unless the resulting valuation is outside the permissible range or rests on a demonstrable misunderstanding.

Importantly, the Court provides a clear restatement of the non hindsight principle in share valuation: once a valuation date is fixed, later developments—whether favourable or unfavourable—do not ordinarily justify reopening findings or altering forecasts that were reasonable at the time. This prevents valuations from becoming perpetually adjustable and preserves finality in commercial disputes. Similarly, while “sense checks” are sometimes appropriate, courts cannot displace a structured and expert driven valuation merely because subsequent events or instinctive impressions cast doubt on the headline figure.

The sole error identified—the misapplication of the SFA facility adjustment—serves as a reminder that even in broad evaluative exercises, courts must apply expert evidence with care. When complex financial instruments are involved, apparently similar numerical outcomes may conceal materially different methodologies, requiring careful scrutiny. The remittal also underscores that appellate courts will intervene where a valuation rests on an internally inconsistent rationale.

Overall, the decision consolidates a trend in Jersey case law: valuation in unfair prejudice cases is an evaluative, not mechanical, exercise; expert evidence must be weighed holistically; and appellate correction is exceptional, reserved for errors that undermine the coherence of the valuation rather than disagreements over its magnitude.
consideration has been overlooked.